DEFA3 and hyperlipidemia: Our results showed that DEFA1/DEFA3 mRNA expression was not significantly different between these groups (p > 0.05; Fig. 3a), i.e., DEFA1/DEFA3 expression was similar between hyperlipidemia and CHD patients.